// App-Quantinova.ai

: Characteristics of patients with and without dialysis dependent chronic kidney disease and anemia receiving blood transfusions and intravenous iron: A report from the DISCOVER CKD retrospective cohort

Researchers

Presenter

  • Eric Wittbrodt

Principal Investigators

  • Juan Jesus Carrero

  • Glen James

  • Steven Fishbane

  • Supriya Kumar

  • Roberto Pecoits-Filho

  • Juan Jose Garcia Sanchez

  • Carol Pollock

  • James Sloand

  • Katarina Hedman

  • David C. Wheeler

Medical Centers

  • Karolinska Institutet, Stockholm, Sweden

  • Division of Nephrology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, United States

  • Royal North Shore Hospital/ University of Sydney, St Leonards, Australia

  • AstraZeneca, Gothenburg, Sweden

  • AstraZeneca, Gaithersberg, MD, United States,

  • Division of Medicine, University College London, London, United Kingdom

  • Arbor Research Collaborative for Health, Ann Arbor, MI

  • School of Medicine, Pontifical Catholic University of Parana, Curitiba, Brazil

  • Astra Zeneca, Cambridge, United Kingdom

Locations

  • Sweden

  • United States

  • Australia

  • United Kingdom

  • Brazil

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Blood/haematological Diseases

Disease

  • Chronic kidney disease

  • Anemia

Biomarkers

  • Paraoxonase 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved